![The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study - The Lancet The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study - The Lancet](https://www.thelancet.com/cms/attachment/746b2133-618b-4b5b-9922-bee2725d1a48/gr1.gif)
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study - The Lancet
![National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: Analysis of 2004–2019 demographic surveillance data in rural Bangladesh - eClinicalMedicine National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: Analysis of 2004–2019 demographic surveillance data in rural Bangladesh - eClinicalMedicine](https://www.thelancet.com/cms/attachment/8da01292-719d-42c6-99f3-3cf1f4475bf1/gr1_lrg.jpg)
National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: Analysis of 2004–2019 demographic surveillance data in rural Bangladesh - eClinicalMedicine
![Frontiers | Poliovirus Vaccination Induces a Humoral Immune Response That Cross Reacts With SARS-CoV-2 Frontiers | Poliovirus Vaccination Induces a Humoral Immune Response That Cross Reacts With SARS-CoV-2](https://www.frontiersin.org/files/MyHome%20Article%20Library/710010/710010_Thumb_400.jpg)